Aim: It is well established that people gain weight after smoking cessation; however, changes in cardiovascular risk factors and the estimated risk of coronary heart disease following smoking cessation have yet to be fully clarified. Methods: The participants were 1,995 Japanese male workers at 11 workplaces who participated continuously in the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Participants with a smoking habit had cardiovascular risk factors measured at baseline and over a 4-yr period. Their estimated incidence risk of coronary heart disease was calculated by a formula based on a previous cohort study. Results: Successful abstainers who had stopped smoking for at least 6 months at the end of the follow-up period had weight gains of approximately 2 kg. These subjects had significant worsening of the following factors compared to continuing smokers: systolic and diastolic blood pressure, total cholesterol, triglyceride and fasting blood sugar levels. In contrast, HDL-cholesterol levels improved significantly. When the overall instantaneous incidence risk of coronary heart disease prior to smoking cessation was assumed to be 1.00, the estimated risk was 0.76 (95%CI: 0.68 − 0.85) in successful abstainers due mainly to smoking cessation, despite weight gain. Conclusion: Although smoking cessation leads to weight gain, the estimated risk of coronary heart disease was decreased markedly by smoking cessation. 
Introduction
Smoking is an important risk factor for cancer and cardiovascular disease 1, 2) . The national health guidelines from 2001 to 2010 'Healthy Japan 21', has set goals for an anti-smoking campaign 3) . In recent years, the importance of practical strategies against smoking has been widely recognized. This has included increasing support for smoking cessation, such as smoking cessation guidance and coverage of treatment for nicotine addiction by public medical insurance in Japan 4) . The number of smokers among Japanese males has been decreasing every year, with the prevalence of smoking being 39.3% in 2005 5) . However, the prevalence is still very high in Japanese males compared to males in Europe and the USA, and therefore effective ways for further decreasing prevalence are necessary 6) . Weight gain after quitting smoking is commonly cited as the primary reason for not trying to quit and also for relapsing after cessation. It is widely known that people gain weight after smoking cessation, and there are many reports from Europe and the USA describing this effect 7) . There are also reports of weight changes after smoking cessation in Japanese subjects, many of which have described significant weight gain after smoking cessation [8] [9] [10] . However, it has not been clarified fully how other cardiovascular disease risk factors, such as blood pressure and cholesterol levels, change with weight gain after smoking cessation and how these changes affect the risk of coronary heart disease.
The objectives of this study were to examine: (1) the level of weight gain following smoking cessation in Japanese male workers, (2) the changes in cardiovascular risk factors that accompanied smoking cessation and weight gain, and (3) changes in the estimated risk of coronary heart disease due to smoking cessation, weight gain and changes in other risk factors.
Subjects and Methods

Study Population
We used the follow-up survey data from a large interventional study named the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. The details of this study have been described elsewhere [11] [12] [13] . Briefly, the HIPOP-OHP study was conducted using both a population strategy and a high-risk strategy to establish preventative measures for improving cardiovascular risk factors. The study was of 6-yr duration, conducted from 1998 on subjects from 12 workplaces throughout Japan. The 12 workplaces participating in the study consisted of 6 sites in an intervention group (companies A − F), and 6 sites in a control group (companies G − L). In the intervention group, individual lifestyle modifications for subjects with positive findings of hypertension, hypercholesterolemia, diabetes or a smoking habit were performed as a high-risk strategy. Environmental improvements were introduced concurrently, based on a population strategy and included improvements in company cafeterias, promotional campaigns to increase physical activity and inspection of the designated smoking areas. In the control group, only teaching materials for individual lifestyle modification were provided. The sites in the intervention group included the Tokyo headquarters of a life insurance company (company A) and factories involved in the manufacture of electrical or chemical products (companies B − F). The sites in the control group included the factory of a chemical company (company H), four electrical product manufacturers (companies G and I − K) and the laboratory of an electrical products manufacturer (Company L). The 2004 survey could not be conducted in Company A as it had merged with another company in 2003; therefore, the analyses in this study were performed on employees of the remaining 11 companies.
The subjects were 1,995 smokers at baseline, aged 19 to 69 yrs, who worked at the aforementioned companies at the baseline examination (1999 or 2000) and 4 years later (2003 − 2004) . Of the 1,995 smokers, 893 did not have blood samples collected. Exclusion of these subjects resulted in 1,102 smokers being included at baseline.
Data Collection and Standardization
All data were collected by standardized methods 11) . To measure the lipid levels in each participant, the companies established a contract with a clinical laboratory, with blood testing being standardized by the US Cholesterol Reference Method Laboratory Network (CRMLN) 14) . Duplicate measurements of blood pressure were obtained from each participant, after they had rested quietly for exactly five minutes. These measurements used the same calibrated automatic sphygmomanometer (BP-103iII; Nippon Colin, Komaki, Japan), except for Company L which used the TM-2654 and TM-2656 systems (A&D Co., Ltd., Tokyo, Japan). Smoking status was examined using a self-administered questionnaire, with this survey being conducted annually.
In this study, individuals with a smoking habit at baseline were followed up for 4 years. The following factors were included in the analyses: changes in smoking status, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP) and levels of total cholesterol (T-chol), HDL cholesterol (HDL-chol), triglyceride (TG) and fasting blood sugar (FBS). A "continuing smoker" was defined as an indi-vidual who was a smoker at baseline and 4 years later. A "successful abstainer" was defined as an individual who was a smoker at baseline but who had stopped smoking by the time of the survey 4 years later and had not been smoking for at least 6 months prior to that survey. Individuals who were taking either antihypertensive or lipid-lowering agents were excluded from the study in order to eliminate the effects of these agents on the analyses. In addition, only subjects whose blood was collected in the fasting state were included in the analyses of TG and FBS.
The Framingham scale is used frequently for assessing coronary heart disease risk; however, it remains controversial whether this scale is applicable for use in non-Western populations 15) . The study by Kitamura et al. 16 ) is a well-designed prospective study on the development of coronary heart disease in a Japanese worksite population. This study followed 6408 workers in Osaka for a period of 7.7 years. The relative risk of each cardiovascular risk factor was determined using a Cox proportional hazard model, and the value of (beta) for each risk factor was then calculated. In the HIPOP-OHP study, these findings were used for baseline prediction of the relative risk of coronary heart disease 11) . In our study, the relative risk of coronary heart disease at baseline in successful abstainers was defined as 1.00. The relative risk of coronary heart disease in the final year of the study (Rm_s) was calculated for each individual using the formula detailed below. We used SBP, TC, HDL-chol and smoking as independent variables as these were shown to have significant associations with the incidence of coronary heart disease by Kitamura et al. 16) Baseline SBP was expressed as SBP1 and SBP in the final year of the study as SBP5. Similar notations were used for TC, HDL and Sm, where Sm represents the number of cigarettes the subject smoked each day. For successful abstainers, the number of cigarettes was zero at the time of the survey in the final year; therefore, their Logarithmic conversion was performed on Rm_s, followed by determination of the mean value. The mean value and 95% confidence interval were then converted back to anti-logarithmic values.
Statistical Analysis
Changes in weight in continuing smokers and successful abstainers were compared using the unpaired t -test. Analysis of covariance (ANCOVA) adjusted for age at baseline was used to compare changes in BMI, SBP, DBP, T-chol, HDL-chol, TG and FBS between continuing smokers and successful abstainers. SPSS ver. 15.0 for Windows was used for statistical analyses. The level of significance was set at 5%. Table 1 shows the baseline characteristics of the patients included in the analysis and also changes in weight after four years. There were 985 smokers who continued to smoke during the 4 years after baseline and 117 successful abstainers who smoked at baseline but had stopped smoking for at least 6 months prior to the survey at 4 years. Of the 117 successful abstainers, 26 had stopped smoking for ≥ 6 months and 1 year, 46 people had stopped smoking for ≥ 1 year and 2 years and 45 had stopped smoking for ≥ 2 years. The continuing smokers gained 0.5 kg and the successful abstainers gained 2.4 kg from baseline to the time of the survey at 4 years. This weight gain in the successful abstainers was statistically significant. ful abstainers from baseline to 4 years later. Mean BMI increased 0.2 kg/m 2 in continuing smokers and 0.9 kg/m 2 in successful abstainers over the 4-yr period of the study. SBP increased 0.9 mmHg in continuing smokers and 4.9 mmHg in successful abstainers, T-chol increased 5.4 mg/dL in continuing smokers and 12.1 mg/dL in successful abstainers and HDL-chol increased 0.2 mg/dL in continuing smokers and 3.7 mg/dL in successful abstainers. In people who had fasting blood collected, TG decreased 6.2 mg/dL in continuing smokers but increased 24.2 mg/dL in successful abstainers, while blood sugar level increased 4.8 mg/dL in continuing smokers and 7.0 mg/dL in successful abstainers. All of the following factors increased significantly in successful abstainers from baseline to the time of the 4yr survey: BMI, SBP, DBP, T-chol, HDL-chol, TG and FBS. When changes over the 4-yr period were examined by dividing the subjects into either intervention or control groups, there was no difference in the trend of the changes between these two groups. Table 3 shows the overall instantaneous risk of coronary heart disease (Rm_s) for successful abstainers. The risk was determined based on the test results recorded in the final year (i.e., after smoking cessation). If the risk at baseline (before smoking cessation) was set at 1, the relative risk was 0.76 (95% CI: 0.68 − 0.85) in the final year, when the period of smoking cessation was not taken into account. The relative risk was 0.69 (95% CI: 0.67 − 0.71) assuming weight and other cardiovascular disease risk factors remained unchanged following smoking cessation. The following results were obtained if the risk for coronary heart disease in the final year relative to baseline was determined considering only SBP, T-chol, and HDL-chol, with no consideration being given to changes in the number of cigarettes smoked: 1.10 (95% CI: 0.98 − 1.22) for continuing smokers and 1.11 (95% CI: 1.07 − 1.15) for successful abstainers.
Results
Discussion
In this study, we analyzed changes in weight and cardiovascular risk factors following smoking cessation. We also calculated changes in the estimated incidence risk of coronary heart disease due to weight gain. Our results showed that successful abstainers who had stopped smoking for at least 6 months had weight gains of approximately 2 kg. Compared to continuing smokers, these subjects had significant worsening over the following 4 years in systolic and diastolic blood pressure and levels of total cholesterol, triglyceride and fasting blood sugar. In contrast, HDLchol levels improved significantly over the 4-yr period in successful abstainers compared to continuing smokers. When the overall instantaneous incidence risk of coronary heart disease prior to smoking cessation was assumed to be equal to 1.00, the estimated risk was 0.76, despite the gain in weight and worsening of some cardiovascular risk factors.
There are reports on weight changes due to ii) Estimated risk of coronary heart disease 4 years later, assuming SBP, T-Chol, and HDL-Chol were unchanged after smoking cessation.
smoking cessation from studies in both Europe and the USA. There have also been various reports from Japan [7] [8] [9] [10] . Although weight gain varies according to the period of smoking cessation, the majority of reports state that weight gain is observed after smoking cessation. In these earlier reports, mean weight gain after smoking cessation was approximately 2 − 3 kg, similar to the mean weight gain of 2.4 kg seen in our study. There are only a small number of reports on changes in cardiovascular risk factors, such as blood pressure and serum lipid levels, following smoking cessation, with studies indicating that blood pressure and lipid levels worsen as a result of weight increases associated with cessation 17) . In our study, blood pressure and mean levels of serum total cholesterol, triglyceride and blood sugar worsened in successful abstainers compared with continuing smokers in the 4-yr follow-up period, primarily as a consequence of weight gain. Several factors are considered to be involved in the mechanism of weight gain after smoking cessation and include increased calorie intake, decreased resting metabolic rate and genetic factors 7) . In our study, we assumed that the relative risk for coronary heart disease at baseline (i.e., before smoking cessation) was 1.00. The estimated relative risk after smoking cessation was calculated as 0.76 in successful abstainers, a value that indicates a significantly decreased risk. We calculated the relative risks using independent variables, systolic blood pressure, total cholesterol and HDL cholesterol levels and the number of cigarettes smoked. Compared with continuing smokers, successful abstainers had significant increases in SBP and total cholesterol levels associated with the weight gain that occurred after smoking cessation. However, when cigarettes smoked became zero and HDL cholesterol increased, the deterioration in SBP and T-Chol levels associated with weight gain was offset by an increase in HDL cholesterol, and mainly by smoking cessation. When our results are interpreted according to the multivariable relative risk of coronary heart disease reported by Kitamura 16) , we consider that smoking cessation per sé represents an important determinant for reducing coronary risk, irrespective of other risk factors.
Generally, it has been reported that smoking increases T-chol and TG and decreases HDL-chol levels 18) . Unfortunately, in the present study, serum levels of T-chol and TG increased after smoking cessation due to weight gain. We believe that T-chol and TG levels might have decreased if body weight had not increased. If we assumed no changes in body weight, systolic blood pressure or total cholesterol level following smoking cessation, the risk for coronary heart disease was found to decrease further. In this regard, there needs to be provision for programs aimed at preventing weight gain following smoking cessation.
It is also possible that the reduction in coronary risk may be the consequence of changes in lifestyle factors other than smoking cessation, as it appears that subjects who want to stop smoking are likely to improve many of their other lifestyle habits. For example, an increased HDL-chol level may be caused by not only smoking cessation but also by a subject increasing their frequency or level of exercise. As reported previously 13) , although mean serum levels of HDL-chol in the HIPOP-OHP study increased significantly in the intervention group due to increased physical activity, in the present study we observed an increase in HDL-chol of similar magnitude in successful abstainers in both the intervention and control groups. On the basis of these findings, we reiterate that smoking cessation per sé is an important determinant for reducing coronary risk.
In the present study, the magnitude of the reduction in estimated coronary risk appeared to fall with longer cessation periods. Earlier studies in Japan reported that the reduction in coronary risk after smoking cessation occurred within 2 years, and that most of the benefit occurred 10 − 14 years after cessation 19, 20) . This is not to say that the risk of coronary heart disease in successful abstainers decreases immediately to the level of subjects who have never smoked 21, 22) . Accordingly, it remains unknown how weight and cardiovascular disease risk factors may change with a longer duration of smoking cessation. A study with a longer follow-up period is therefore required to address this question.
This study calculated the relative risk of coronary heart disease, based on only one equation reported in the study of Kitamura et al. 16) . There are several equations for calculating relative risk, such as the Framingham scale, and it is possible that another equation might have produced a different result; however, it remains controversial whether the Framingham scale is applicable for use in non-Western populations 15) , whereas the study by Kitamura and co-workers is a well-designed prospective study on the development of coronary heart disease in a Japanese worksite population. As the HIPOP-OHP Study was conducted in 12 workplaces throughout Japan and had similar characteristics to Kitamura's study, we chose to use the equation described in that report.
The present study had several limitations. Firstly, the data used in the analyses were collected as part of a large-scale interventional study, the HIPOP-OHP study, which used comprehensive non-pharmacologi-cal intervention strategies that included smoking cessation and also physical activity and nutrition. In addition, the study included interventions for highrisk people with hypertension, hyperlipidemia or diabetes. It is therefore possible that the weight gain and deterioration in blood pressure, lipid and blood sugar levels that occurred following smoking cessation may have been underestimated compared with the general population; however, additional analysis involving stratification of the data into intervention and control groups showed similar trends. Although we have already reported that smokers in the intervention group were more likely to quit smoking than subjects in the control group in the HIPOP-OHP study 12) , the level of individual changes in cardiovascular risk factors due to weight gain after smoking cessation was almost the same in the two groups. Secondly, we estimated the risk for coronary heart disease using data from a cohort study carried out by Kitamura et al. 16) ; however, as that study did not measure triglyceride and fasting blood sugar, we did not include these variables when estimating the incidence of coronary heart disease after smoking cessation. Accordingly, the estimated risk for successful abstainers may be higher than the value calculated in this study.
In conclusion, this study indicates that smoking cessation leads to weight gain and worsening of some cardiovascular risk factors; however, the estimated risk of coronary heart disease decreased markedly following smoking cessation, while HDL cholesterol levels also increased. These results suggest that coronary risk reduction after smoking cessation may be further decreased by inhibiting weight gain. It is necessary to disseminate to the public that many benefits are attained by stopping smoking, despite the associated weight gain. At present, there is no interventional method available that effectively controls weight gain after smoking cessation. Future research and development of an effective method is therefore desirable [23] [24] [25] [26] .
